Sep 16, 2020 / 07:30PM GMT
David Reed Risinger - Morgan Stanley, Research Division - MD in Equity Research and United States Pharmaceuticals Analyst
So good afternoon everyone. Thank you so much for joining us for this session with Eli Lilly. It's very much my pleasure to welcome Josh Smiley, the company's CFO.
So I just need to start with the standard disclaimer, so I need to read that quickly. Please note that this webcast is for Morgan Stanley's clients and appropriate Morgan Stanley employees only. It's not for members of the press. If you're a member the press, please disconnect and reach out separately. For important disclosures, please see www.morganstanley.com/researchdisclosures. If you have any questions, reach out to your sales representative.
So with us, we have Josh Smiley, as I mentioned. He's been with Lilly since 1995 and has held a number of different roles in the commercial, finance and operational excellence teams; and also Sara Smith from Investor Relations is joining us as well.
Eli Lilly and Co at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Sep 17, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers